specific knockdown of egfr and plk1 gene expression in u87

1
Specific knockdown of EGFR and PLK1 gene expression in U87 GBM cells with radio frequency energy Ilya V Ulasov 1 , Haidn Foster 1 , Mike Butters 2 , Jae-Geun Yoon 1 , Xavier Figueroa 2 , Parvinder Hothi 1 , John Butters 2 , & Charles Cobbs 1 1 Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute. 550 17 th Ave, Seattle, WA, 98104, USA; 2 Nativis Inc, 219 Terry Ave North, Seattle, WA, 98109, USA Mock ABSTRACT Every molecule contains a unique electromagnetic radio frequency energy (RFE) potential. Using superconducting quantum interference device (SQUID) technology, we have developed a technique to specifically record the RFE of a given molecule, and then expose living tissues to the specific and precise oscillating magnetic RFE field of that molecule. We discovered that exposure of a molecule’s unique RFE through a transmitting electromagnetic coil device can specifically impact biological systems as if the authentic molecule were present. We have recently acquired the RFE signals of siRNA oligonucleotide molecules. Here, we demonstrate for the first time that disruption of signaling pathway using ultra-low radio frequency energy (ulRFE™) can significantly inhibit target mRNA and protein expression. EGFR and PLK1 blockade by ulRFE caused a 30-70% reduction of mRNA expression and ~40% protein expression vs. control treated cells. Moreover, using RNA microarray and protein array we validated specificity of cellular EGFR knockdown. Finally, we demonstrated that RFE-mediated knockdown of EGFR and PLK1 was associated with decreased U87 GBM cell proliferation. These are the first results to demonstrate that specific ulRFE signals can be used to knock down specific gene products, impacting key pathways associated with cancer signaling. Materials & Methods Cell lines: U87 Human glioblastoma (ATCC) PCR: RT-PCR was performed using SYBR Green Mastermix (Life Technologies-Thermo Fisher, USA) or TaqMan Universal Master Mix II (Applied Biosystems, CA, USA). Gene Array:Total RNA from U87 cells treated with Mock, NCsiRNA, siEGFR and RFE-siEGFR for 4 or 12 hrs was isolated using RNeasy Mini Kit (Qiagen, CA, USA). The expression of 84 cancer-related genes was assessed by real-time PCR using Human Cancer Drug Targets RT2 ProfilerTM PCR Array (Qiagen, PAHS-507z). Western Blot: mouse monoclonal anti-EGFR antibodies (#sc-03, Santa Cruz Biotechnology, TX, USA) mouse monoclonal anti-PLK1 (#sc-17783, Santa Cruz Biotechnology, TX, USA) and polyclonal rabbit anti-GAPDH antibody (sc-25778, Santa Cruz Biotechnology, TX, USA). As secondary antibodies: goat anti-rabbit HRP-conjugated (#1706515, Bio-Rad, CA, USA), goat anti-mouse HRP- conjugated (#1721011, Bio-Rad, CA, USA) antibodies used for the Western blotting. Figure 1 – Plastic incubator (A) and ulRFE transmission system (B) used in the experiments with U87 cells. The blue ring is the transmission antenna and the white box with the LCD display is the Voyager transmitter. (C) Diagram of exposure set up for U87 Cells in (A). A B C Figure 2 – Reduction in mRNA and protein levels using ulRFE that targets EGFR expression (EGFR ulRFE). Transfection without siRNA (Mock), transfection with non- coding siRNA (NC siRNA) and EGFR targeting siRNA (EGFR siRNA). The EGFR ulRFE reduces both EGFR mRNA (A) and protein (B) levels in U87 cells. Values between blots (B) are GAPDH- adjusted EGFR expression. Both EGFR siRNA and EGFR ulRFE significantly reduced expression of EGFR in U87 cells (*P< 0.05). A B Figure 3 – The EGFR ulRFE specifically targets EGFR expression in a similar fashion as physical EGFR siRNA. Gene chip array (A) demonstrates a near identical profile in gene expression between the two treatments. Fold regulation (B) reveals subtle differences in gene expression between siEGFR and ulRFE EGFR. (C) Reduction in protein levels associated with downstream EGFR targets are 2-4 fold for ulRFE vs. Mock. A B C A B Figure 4 – Reduction in mRNA and protein levels using ulRFE that targets PLK1 expression (PLK1 ulRFE). Transfection without siRNA (Mock), transfection with non- coding siRNA (NC siRNA) and PLK1 targeting siRNA (PLK1 siRNA). The PLK1 ulRFE reduces both PLK1 mRNA (A) and protein (B) levels in U87 cells. Values between blots (B) are GAPDH- adjusted PLK1 expression. Both PLK1 siRNA and PLK1 ulRFE significantly reduced mRNA expression (*P< 0.05). * * * * * * Figure 5 – Effects of EGFR and PLK1 inhibition in cultured human GBM. Left, primary cultures from 2 patients with resected GBM tumors (GBM2 and GBM3). Expression levels of EGFR vary from each sample, but exposure to the EGFR ulRFE reduces the expression of EGFR and the production of neurospheres. Right, effects of PLK1 siRNA and PLK1 ulRFE exposure in U87 cultures. Both assays are at 72 hours exposure. PLK1

Upload: others

Post on 14-Mar-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

SpecificknockdownofEGFRandPLK1geneexpressioninU87GBMcellswithradiofrequencyenergy

IlyaVUlasov1,Haidn Foster1,MikeButters2,Jae-Geun Yoon1,XavierFigueroa2,Parvinder Hothi1,JohnButters2,&CharlesCobbs11IvyCenterforAdvancedBrainTumorTreatment,SwedishNeuroscienceInstitute.55017th Ave,Seattle,WA,98104,USA;2NativisInc,219TerryAveNorth,Seattle,WA,98109,USA

Mock

ABSTRACTEverymoleculecontainsauniqueelectromagneticradiofrequencyenergy(RFE)potential.Usingsuperconductingquantuminterferencedevice(SQUID)technology,wehavedevelopedatechniquetospecificallyrecordtheRFEofagivenmolecule,andthenexposelivingtissuestothespecificandpreciseoscillatingmagneticRFEfieldofthatmolecule.Wediscoveredthatexposureofamolecule’suniqueRFEthroughatransmittingelectromagneticcoildevicecanspecificallyimpactbiologicalsystemsasiftheauthenticmoleculewerepresent.WehaverecentlyacquiredtheRFEsignalsofsiRNAoligonucleotidemolecules.Here,wedemonstrateforthefirsttimethatdisruptionofsignalingpathwayusingultra-lowradiofrequencyenergy(ulRFE™)cansignificantlyinhibittargetmRNAandproteinexpression.EGFRandPLK1blockadebyulRFE causeda30-70%reductionofmRNAexpressionand~40%proteinexpressionvs.controltreatedcells.Moreover,usingRNAmicroarrayandproteinarraywevalidatedspecificityofcellularEGFRknockdown.Finally,wedemonstratedthatRFE-mediatedknockdownofEGFRandPLK1wasassociatedwithdecreasedU87GBMcellproliferation.ThesearethefirstresultstodemonstratethatspecificulRFE signalscanbeusedtoknockdownspecificgeneproducts,impactingkeypathwaysassociatedwithcancersignaling.

Materials&MethodsCelllines:U87Humanglioblastoma(ATCC)PCR:RT-PCRwasperformedusingSYBRGreenMastermix (LifeTechnologies-Thermo Fisher,USA)orTaqMan UniversalMasterMixII(AppliedBiosystems,CA,USA).GeneArray:Total RNAfromU87cellstreatedwithMock,NCsiRNA,siEGFR andRFE-siEGFR for4or12hrs wasisolatedusingRNeasyMiniKit(Qiagen,CA,USA).Theexpressionof84cancer-relatedgeneswasassessedbyreal-timePCRusingHumanCancerDrugTargetsRT2ProfilerTM PCRArray(Qiagen,PAHS-507z).WesternBlot:mousemonoclonalanti-EGFRantibodies(#sc-03,SantaCruzBiotechnology,TX,USA)mousemonoclonalanti-PLK1(#sc-17783,SantaCruzBiotechnology,TX,USA)andpolyclonalrabbitanti-GAPDHantibody(sc-25778,SantaCruzBiotechnology,TX,USA).Assecondaryantibodies:goatanti-rabbitHRP-conjugated(#1706515,Bio-Rad,CA,USA),goatanti-mouseHRP-conjugated(#1721011,Bio-Rad,CA,USA)antibodiesusedfortheWesternblotting.

Figure1– Plasticincubator(A)andulRFE transmissionsystem(B)usedintheexperimentswithU87cells.TheblueringisthetransmissionantennaandthewhiteboxwiththeLCDdisplayistheVoyagertransmitter.(C)DiagramofexposuresetupforU87Cellsin(A).

A B C

Figure2 – ReductioninmRNAandproteinlevelsusingulRFE thattargetsEGFRexpression(EGFRulRFE).TransfectionwithoutsiRNA(Mock),transfectionwithnon-codingsiRNA(NCsiRNA)andEGFRtargetingsiRNA(EGFRsiRNA).TheEGFRulRFEreducesbothEGFRmRNA(A)andprotein(B)levelsinU87cells.Valuesbetweenblots(B)areGAPDH- adjustedEGFRexpression.BothEGFRsiRNAandEGFRulRFE significantlyreducedexpressionofEGFRinU87cells(*P<0.05).

A B

Figure3 – TheEGFRulRFE specificallytargetsEGFRexpressioninasimilarfashionasphysicalEGFRsiRNA.Genechiparray(A)demonstratesanearidenticalprofileingeneexpressionbetweenthetwotreatments.Foldregulation(B)revealssubtledifferencesingeneexpressionbetweensiEGFR andulRFE EGFR.(C)ReductioninproteinlevelsassociatedwithdownstreamEGFRtargetsare2-4foldforulRFE vs.Mock.

A B

C

A B

Figure4– ReductioninmRNAandproteinlevelsusingulRFE thattargetsPLK1expression(PLK1ulRFE).TransfectionwithoutsiRNA(Mock),transfectionwithnon-codingsiRNA(NCsiRNA)andPLK1targetingsiRNA(PLK1siRNA).ThePLK1ulRFE reducesbothPLK1mRNA(A)andprotein(B)levelsinU87cells.Valuesbetweenblots(B)areGAPDH- adjustedPLK1expression.BothPLK1siRNAandPLK1ulRFE significantlyreducedmRNAexpression(*P<0.05).

* * * * **

Figure5– EffectsofEGFRandPLK1inhibitioninculturedhumanGBM.Left,primaryculturesfrom2patientswithresectedGBMtumors(GBM2andGBM3).ExpressionlevelsofEGFRvaryfromeachsample,butexposuretotheEGFRulRFE reducestheexpressionofEGFRandtheproductionofneurospheres.Right,effectsofPLK1siRNAandPLK1ulRFE exposureinU87cultures.Bothassaysareat72hoursexposure.

PLK1